Spots Global Cancer Trial Database for pelvic neoplasms
Every month we try and update this database with for pelvic neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy | NCT00191646 | Genital Neoplas... Fallopian Tube ... Ovarian Neoplas... Pelvic Neoplasm... Peritoneal Neop... | Gemcitabine Paclitaxel Carboplatin | 18 Years - | Eli Lilly and Company | |
Malignant Pediatric Pelvic Tumors: A Retrospective Study | NCT02557256 | Abdominal Neopl... Pelvic Neoplasm... | - 18 Years | Assiut University | ||
Treatment of Hemorrhagic Radiation Proctitis Using the Halo System | NCT01103492 | Pelvic Neoplasm... | HALO90 Ablation... | 18 Years - | University Hospitals Cleveland Medical Center | |
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy | NCT00191646 | Genital Neoplas... Fallopian Tube ... Ovarian Neoplas... Pelvic Neoplasm... Peritoneal Neop... | Gemcitabine Paclitaxel Carboplatin | 18 Years - | Eli Lilly and Company | |
Treatment of Hemorrhagic Radiation Proctitis Using the Halo System | NCT01103492 | Pelvic Neoplasm... | HALO90 Ablation... | 18 Years - | University Hospitals Cleveland Medical Center | |
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia | NCT03007771 | Healthy Partici... Pelvic Neoplasm... Soft-tissue Sar... Bladder Cancer Cervical Cancer Rectal Cancer | Magnetic Resona... | 18 Years - | Washington University School of Medicine | |
Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors | NCT00385177 | Breast Neoplasm... Colorectal Neop... Pancreatic Neop... Pelvic Neoplasm... Lung Neoplasms | SN2310 Injectab... | 18 Years - | Achieve Life Sciences | |
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy | NCT00191646 | Genital Neoplas... Fallopian Tube ... Ovarian Neoplas... Pelvic Neoplasm... Peritoneal Neop... | Gemcitabine Paclitaxel Carboplatin | 18 Years - | Eli Lilly and Company | |
Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors | NCT00385177 | Breast Neoplasm... Colorectal Neop... Pancreatic Neop... Pelvic Neoplasm... Lung Neoplasms | SN2310 Injectab... | 18 Years - | Achieve Life Sciences | |
Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization | NCT03622983 | Pelvic Neoplasm... Endometriosis | collection of s... | 18 Years - | Centre Hospitalier Intercommunal Creteil | |
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. | NCT00191607 | Genital Neoplas... Fallopian Tube ... Ovarian Neoplas... Pelvic Neoplasm... Peritoneal Neop... | Gemcitabine liposomal doxor... | 18 Years - | Eli Lilly and Company |